Archiv der Kategorie ‘Analyst Rating‘

Western Union (WU) Upgrade from Hold to Buy – Analyst rating from Standpoint Research

Wednesday, den 30. October 2013

Thomson Reuters (TRI) Upgrade from Sector Perform to Outperform – Analyst rating from RBC Capital Mkts

Wednesday, den 30. October 2013

First Busey Corp (BUSE) Upgrade from Mkt Perform to Outperform – Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Oceaneering Intl (OII) Upgrade from Sector Perform to Sector Outperform – Analyst rating from Howard Weil

Wednesday, den 30. October 2013

Facebook (FB) Upgrade from Neutral to Buy – Analyst rating from BTIG Research

Wednesday, den 30. October 2013

Shire plc (SHPG) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Sarepta Therapeutics (SRPT) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Novavax (NVAX) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Raptor Pharma (RPTP) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Michael Kors (KORS) Initial Recommendation Buy Analyst rating from Maxim Group

Wednesday, den 30. October 2013

Jazz Pharma (JAZZ) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Kythera Biopharma (KYTH) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Hipcricket (HIPP) Initial Recommendation Buy Analyst rating from Ladenburg Thalmann

Wednesday, den 30. October 2013

Hannon Armstrong Sust. Infr. (HASI) Initial Recommendation Buy Analyst rating from UBS

Wednesday, den 30. October 2013

Endo Health (ENDP) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Forest Labs (FRX) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Ecolab (ECL) Initial Recommendation Buy Analyst rating from UBS

Wednesday, den 30. October 2013

DS Healthcare Group (DSKX) Initial Recommendation Buy Analyst rating from Aegis Capital

Wednesday, den 30. October 2013

Amarin (AMRN) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Biogen Idec (BIIB) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Alkermes (ALKS) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Aegerion Pharma (AEGR) Initial Recommendation Outperform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Acorda Therapeutics (ACOR) Initial Recommendation Mkt Perform Analyst rating from FBR Capital

Wednesday, den 30. October 2013

Union Pacific (UNP) Downgrade from Outperform to Neutral – Analyst rating from Robert W. Baird

Wednesday, den 30. October 2013

Vertex Pharm (VRTX) Downgrade from Buy to Neutral – Analyst rating from Summer Street Research

Wednesday, den 30. October 2013

U.S. Steel (X) Downgrade from Buy to Hold – Analyst rating from Deutsche Bank

Wednesday, den 30. October 2013

Rosetta Genomics (ROSG) Downgrade from Buy to Hold – Analyst rating from Aegis Capital

Wednesday, den 30. October 2013

InterActiveCorp (IACI) Downgrade from Buy to Hold – Analyst rating from Stifel

Wednesday, den 30. October 2013

Questcor Pharma (QCOR) Downgrade from Buy to Fair Value – Analyst rating from CRT Capital

Wednesday, den 30. October 2013

Dana Holding (DAN) Downgrade from Buy to Fair Value – Analyst rating from CRT Capital

Wednesday, den 30. October 2013

Cirrus Logic (CRUS) Downgrade from Equal Weight to Underweight – Analyst rating from Barclays

Wednesday, den 30. October 2013

Bed Bath & Beyond (BBBY) Downgrade from Buy to Hold – Analyst rating from Canaccord Genuity

Wednesday, den 30. October 2013

AVG Tech (AVG) Downgrade from Buy to Hold – Analyst rating from BWS Financial

Wednesday, den 30. October 2013

Xylem (XYL) Upgrade from Hold to Buy – Analyst rating from Brean Capital

Tuesday, den 29. October 2013

Potbelly (PBPB) Initial Recommendation Neutral Analyst rating from Robert W. Baird

Tuesday, den 29. October 2013

Potbelly (PBPB) Initial Recommendation Mkt Perform Analyst rating from William Blair

Tuesday, den 29. October 2013

Omnicom (OMC) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

OCI Partners (OCIP) Initial Recommendation Overweight Analyst rating from Barclays

Tuesday, den 29. October 2013

Nielsen (NLSN) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

McKesson (MCK) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

Moody’s (MCO) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

McGraw-Hill Financial (MHFI) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

Gamestop (GME) Initial Recommendation Buy Analyst rating from Stifel

Tuesday, den 29. October 2013

Cherry Hill Mortgage (CHMI) Initial Recommendation Outperform Analyst rating from FBR Capital

Tuesday, den 29. October 2013

ClickSoftware (CKSW) Initial Recommendation Outperform Analyst rating from Northland Capital

Tuesday, den 29. October 2013